Vancouver Mayor Ken Sim has unveiled a plan to revitalize the city's troubled Downtown Eastside that includes pausing the construction of net new supportive housing units.
Novo Nordisk said a Phase 1b/2a clinical trial of amycretin, which activates both the GLP-1 and amylin receptors to help manage blood sugar and weight, achieved weight loss of 22% on a 20 milligram ...